Belite Bio, Inc. ADR share price logo

Belite Bio, Inc. ADR

NASDAQ: BLTE

Mid Cap

$175.35

+1.95

(+1.12%)

as on

Belite Bio, Inc. ADR Stock Performance

as on September 23, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $173.66
    $177.93
    downward going graph

    0.96%

    Downside

    1.47%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $68.21
    $200.00
    downward going graph

    61.10%

    Downside

    14.06%

    Upside

    downward going graph

Belite Bio, Inc. ADR share price movements today

Previous Close
$173.40
Open
$174.97
Volume
242.4K
Market Cap
$7.0B
Day's Low - High
$173.66 - $177.93
52 Week Low - High
$68.21 - $200.00

Belite Bio, Inc. ADR Historical Returns

1 Month Return
+ 8.87 %
3 Month Return
+ 20.86 %
1 Year Return
+ 146.8 %
3 Year Return
+ 456.67 %
5 Year Return
0 %

Belite Bio, Inc. ADR Stock Fundamentals & Key Indicators

Check Belite Bio, Inc. ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.0B

EPS (TTM)

-2.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-61.39

Industry PE ratio

-13.42

PEG Ratio

1.213037342894105

EBITDA

-114.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-15.65%

Belite Bio, Inc. ADR Stock Valuation

Track how Belite Bio, Inc. ADR P/E has moved over time to understand its valuation trends.

Belite Bio, Inc. ADR in the last 5 years

  • Overview

  • Trends

Lowest (-69.25x)

December 31, 2025

Today (-69.25x)

December 31, 2025

Industry (-13.42x)

December 31, 2025

Highest (-26.40x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -69.25x

Belite Bio, Inc. ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Belite Bio, Inc. ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$7.0BNA-61.390.00%0.00%
Neutral$69.0B-59.84%-21.67-12.57%0.00%
StrongBuy$129.4B178.24%29.4986.04%0.00%
Buy$80.8B24.34%19.284.86%0.46%

Stock Returns calculator for Belite Bio, Inc. ADR Stock including INR - Dollar returns

The Belite Bio, Inc. ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Belite Bio, Inc. ADR investment value today

Current value as on today

₹2,66,062

Returns

₹1,66,062

(+166.06%)

Returns from Belite Bio, Inc. ADR Stock

₹1,46,798 (+146.8%)

Dollar Impact

₹19,264 (+19.26%)

Analyst Recommendation on Belite Bio, Inc. ADR Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Belite Bio, Inc. ADR. Average target price of $228.89

Belite Bio, Inc. ADR Share Price Target

Get share price movements and forecasts by analysts on Belite Bio, Inc. ADR.

What analysts predicted

23.39%UPSIDE

Target Price

$228.89

Current Price

$175.35

Analyzed by

7 Analysts

Target

$228.89

Belite Bio, Inc. ADR target price $228.89, a slight upside of 23.39% compared to current price of $175.35. According to 7 analysts rating.

Indian Investors' Interest in Belite Bio, Inc. ADR Stock

Search interest for Belite Bio, Inc. ADR Stock has increased by 297% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:297% versus previous 30 day period

Belite Bio, Inc. ADR Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-8
-10
-9
-11
-15
-17
-23
-28
-32
-34
EBITDA
-7
-9
-8
-7
-14
-16
-21
-30
-26
-34
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
-
0
0
-
0
-
-
Income Before Tax
-7
-9
-8
-10
-14
-16
-21
-25
-26
-28
Income Tax Expense
0
-
-
-
-
-
-
-
-
0
Net Income
-7
-9
-8
-10
-14
-16
-21
-25
-26
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Belite Bio, Inc. ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
-
Operating Income
-5
-9
-12
-31
-39
-84
EBITDA
-5
-9
-12
-31
-35
-77
Interest Expense
0
-
0
0
0
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-5
-9
-12
-31
-36
-77
Income Tax Expense
0
-
-
0
0
-
Net Income
-5
-9
-12
-31
-36
-77
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Belite Bio, Inc. ADR Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
0
0
0
0
0
0
0
0
Operating Cash Flow
-
-
-
-
-
-
-
0
-
-
Investing Cash Flow
-
-
-
-
-
-
-
0
-
-
Financing Cash Flow
-
-
-
-
-
-
-
0
-
-
Change in Cash
-
-
-
-
-
-
-
0
0
-

Belite Bio, Inc. ADR Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-9
-12
-31
-36
-77
Operating Cash Flow
-4
-7
-11
-29
-29
-36
Investing Cash Flow
0
0
0
0
-110
-305
Financing Cash Flow
28
0
36
75
83
663
Change in Cash
23
-8
24
46
-56
321

Mutual Funds that own Belite Bio, Inc. ADR Stock

Check out the Mutual Funds with significant holdings in Belite Bio, Inc. ADR.

Funds
Holdings
Shares Held
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
0.516143%
207862
ALGER FUNDS
0.157185%
63302
MUTUAL FUND SERIES TRUST
0.072074%
29026
Fidelity Concord Street Trust
0.029121%
11728
John Hancock Variable Insurance Trust
0.011918%
4800

Global Institutional Holdings in Belite Bio, Inc. ADR

Funds
Holdings
Peter Kolchinsky
1.07%
Lee Ainslie
0.98%
James E. Flynn
0.89%
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
0.52%
Joseph Edelman
0.38%

Belite Bio, Inc. ADR News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 04:02 PM

    -

    Belite Bio submits NDA for tinlarebant in Japan to treat Stargardt disease type 1 under Sakigake Designation System.

Insights on Belite Bio, Inc. ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BLTE stock has moved up by 8.9%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BLTE has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 607.9% return, outperforming this stock by 461.1%

About Belite Bio, Inc. ADR

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is engineered to modulate vitamin A delivery to the eye, thus preventing the accumulation of detrimental vitamin A metabolites in ocular tissues. Furthermore, Belite Bio is advancing LBS-009, an oral anti-retinol binding protein 4 therapy, through preclinical development. This therapy targets various liver ailments, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Founded in 2016, Belite Bio, Inc. is headquartered in San Diego, California, and operates as a subsidiary of Lin Bioscience International Ltd.
OrganisationBelite Bio, Inc. ADR
Headquarters12750 High Bluff Drive, San Diego, CA, 92130, US
IndustryBiotechnology
CEOYu-Hsin Lin
E-voting on sharesClick here to vote

Key Management of Belite Bio, Inc. ADR

Name

Title

Dr. Yu-Hsin Lin M.B.A., Ph.D.

Chairman of the Board of Directors & CEO

Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.

CFO & Director

Dr. Nathan L. Mata Ph.D.

Chief Scientific Officer

Dr. Hendrik P.N. Scholl M.A., M.D., Ph.D.

Chief Medical Officer

FAQs

What is Belite Bio, Inc. ADR share price today?

Belite Bio, Inc. ADR share price today is $175.35 as on at the close of the market. Belite Bio, Inc. ADR share today touched a day high of $177.93 and a low of $173.66.

What is the 52 week high and 52 week low for Belite Bio, Inc. ADR share?

Belite Bio, Inc. ADR share touched a 52 week high of $200.00 on and a 52 week low of $68.21 on . Belite Bio, Inc. ADR stock price today i.e. is closed at $175.35,which is 12.33% down from its 52 week high and 157.07% up from its 52 week low.

What is Belite Bio, Inc. ADR's market capitalisation today?

Belite Bio, Inc. ADR market capitalisation is $0.01T as on .

How to invest in Belite Bio, Inc. ADR Stock (BLTE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Belite Bio, Inc. ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Belite Bio, Inc. ADR Shares that will get you 0.0086 shares as per Belite Bio, Inc. ADR share price of $175.35 per share as on September 23, 2026 at 8:46 am IST.

What is the minimum amount required to buy Belite Bio, Inc. ADR Stock (BLTE) from India?

Indian investors can start investing in Belite Bio, Inc. ADR (BLTE) shares with as little as ₹95.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in Belite Bio, Inc. ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Belite Bio, Inc. ADR share’s latest price of $175.35 as on September 23, 2026 at 8:46 am IST, you will get 0.0570 shares of Belite Bio, Inc. ADR. Learn more about fractional shares .